MARKET
IPO

EIKN

Eikon Therapeutics
EIKN
NASDAQ
Upcoming IPOs
Expected Listing Date: 2026-02-05
P/E
P/S
P/B
MARKET CAP
INDUSTRY
-0.19~-0.17
-
-
807.28M~908.19M
-
2026-01-28
Public Filing
View Prospectus
Pending
Offering
Price Range: 16.00~18.00
Shares to be Issued: 17.65M
2026-02-04
Offering End Date
Offering Price: Pending
Post IPO Outstanding: 50.45M
2026-02-05
Listed
Alphabet, Amazon, AMD Lead Earnings Wave; Jobs Data On Deck
Seeking Alpha · 2d ago
U.S. IPO Weekly Recap: Trio Of Sizable Listings Underwhelm To Close Out January
Seeking Alpha · 3d ago
Catalyst Watch: Amazon earnings, IPO blitz, gold swings, and the jobs report
Seeking Alpha · 3d ago
Merck reportedly eyeing $30M stake in Eikon Therapeutics’ IPO
Seeking Alpha · 4d ago
About EIKN
Eikon Therapeutics,Inc is a late-stage clinical biopharmaceutical company developing innovative oncology medicines to address serious unmet medical needs through a fully integrated global organization. By combining deep biological expertise with advanced engineering, our experienced leadership team is advancing a high-potential pipeline aimed at transforming cancer treatment.

Webull offers Eikon Therapeutics stock information, including NASDAQ: EIKN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EIKN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading EIKN stock methods without spending real money on the virtual paper trading platform.